Treatment of cyclophosphamide-induced cystitis with prostaglandin E2.
D000287:Administration, Topical; D000293:Adolescent; D003520:Cyclophosphamide / Q000009:adverse effects*; D003556:Cystitis / Q000139:chemically induced / Q000188:drug therapy*; D015232:Dinoprostone; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D008297:Male; D011458:Prostaglandins E / Q000627:therapeutic use*
D011458:Prostaglandins E; D003520:Cyclophosphamide; D015232:Dinoprostone